References

Adeoye, G.O. and M. Ipeayeda, 1994. Schistosoma haematobium infection among school children in Owena Army Barracks, Akure, Nigeria. J. Parasitol., 15: 43-48.

Alves, W., 1949. Miracil D. in urinary Bilharziasis. South Afr. Med. J., 23: 428-431.

Appleton, C.C. and A. Mbaye, 2001. Praziquantel-quality, dosages and markers of resistance. Trends Parasitol., 17: 356-357.
CrossRef  |  Direct Link  |  

Bennett, J.L., T. Day, L. Feng-Tao, M. Ismail and A. Farghaly, 1997. The development of resistance to anthelmintics: A perspective with an emphasis on the antischistosomal drug praziquantel. Exp. Parasitol., 57: 260-267.
CrossRef  |  Direct Link  |  

Blair, D.M., C.V. Meeser, F.G. Loveridge and W.F. Ross, 1949. Urinary schistosomiasis treated with miracil D. Lancet, 253: 344-346.
CrossRef  |  Direct Link  |  

Chan, M.S., N.N.N. Nsowah-Nuamah, S. Adjei, S.T. Wen, A. Hall and D.A.P. Bundy, 1998. Predicting the impact of School-based treatment for urinary schistosomiasis given by the Ghana partnership for child development. Trans. R. Soc. Trop. Med. Hyg., 92: 386-389.
CrossRef  |  Direct Link  |  

Cheesbrough, M., 1999. District Laboratory Practice in Tropical Countries, Part 1. Cambridge University Press, Cambridge, UK., pp: 212-215.

Da Silva, I.M., R. Thiengo, M.J. Conceicao, L. Rey, H.L. Lenzi, E.P. Filho and P.C. Ribeiro, 2005. Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Mem. Inst. Oswaido Cruz., 100: 445-449.
CrossRef  |  

Davis, A. and D.H.C. Wegner, 1979. Multicentre trials of praziquantel in human schistosomiasis: Design and techniques. Bull World Health Organ, 57: 767-771.
Direct Link  |  

Davis, A., J.E. Biles and A.M. Ulrich, 1979. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium. Bull World Health Organ, 57: 773-779.
Direct Link  |  

Doenhoff, M., D. Cioli and G. Kimani, 2000. Praziquantel and the control of schistosomiasis. Parasitol. Today, 16: 364-366.
CrossRef  |  PubMed  |  

Ejima, I.A.A. and A.B. Odaibo, 2010. Urinary schistomiasis in the Niger-Benue Basin of Kogi State, Nigeria. Int. J. Trop. Med., 5: 73-80.
CrossRef  |  Direct Link  |  

El Malatawy, A., A. El Habashy, N. Lechine, H. Dixon, A. Davis and K.E. Mott, 1992. Selective population chemotherapy among schoolchildren in Beheira governorate: The UNICEF/Arab Republic of Egypt/WHO schistosomiasis control project. Bull World Health Organ, 70: 47-56.
Direct Link  |  

Etard, J.F., E. Borel and C. Segala, 1990. Schistosoma haematobium infection in Mauritania: Two years of follow-up after a targeted chemotherapy: A life-table approach of the risk of reinfection. Parasitology, 100: 399-406.
CrossRef  |  Direct Link  |  

Fallon, P.G., J.S. Mubarak, R.E. Fookes, M. Niang, A.E. Butterworth, R.F. Sturrock and M.J. Doenhoff, 1997. Schistosoma mansoni: Maturation rate and drug susceptibility of different geographic isolates. Exp. Parasitol., 86: 29-36.
CrossRef  |  Direct Link  |  

Forsyth, D.M., 1967. Treating urinary schistosomiasis in the field: A clinical trial of Ambilhar, a treatment campaign for a school in an endemic area and a pilot study for a mass-treatment programme. Ann. Trop. Med. Parasitol., 60: 172-181.
PubMed  |  

Gutteridge, W.E., 1982. Chemotherapy. In: Modern Parasitology: A Textbook of Parasitology, Cox, F.E.G. (Ed.). Wiley-Blackwell, London, pp: 287-318.

Hagan, P., C.C. Appleton, G.C. Coles, J.R. Kusel and L.A. Tchuem-Tchuente, 2004. Schistosomiasis control: Keep taking the tablets. Trends Parasitol., 20: 92-97.
CrossRef  |  Direct Link  |  

Herwaldt, B.L., L. Tao, W. van Pelt, V.C.W. Tsang and J.I. Bruce, 1995. Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clin. Infect. Dis., 20: 309-315.
CrossRef  |  Direct Link  |  

Iarotski, L.S. and A. Davis, 1981. The schistosomiasis problem in the world: Results of a WHO questionnaire survey. Bull World Health Organ, 59: 115-127.
Direct Link  |  

Jordan, P. and K. Randall, 1962. Comparison of lucanthone hydrochloride and TWSb in the treatment of Schistosoma haematobium infection in Tanganyika. Trans. R. Soc. Trop. Med. Hyg., 56: 136-142.
CrossRef  |  Direct Link  |  

Kardaman, M.W., M.A. Amin, A. Fenwick, A.K. Chessmond and H.G. Dixon, 1983. A field trial using praziquantel (Biltricide) to treat Schistosoma mansoni and S. haematobium infection in Gezira, Sudan. Ann. Trop. Med. Parasitol., 77: 297-304.

Katz, N., R.S. Rocha and A. Chaves, 1979. Preliminary trials with praziquantel in human infections due to Schistosoma mansoni. Bull World Health Organ, 57: 781-785.
Direct Link  |  

King, C.H., E.M. Muchiri and J.H. Ouma, 2000. Evidence against Rapid Emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg. Infect. Dis., 6: 585-594.
CrossRef  |  Direct Link  |  

Laurent, C., F. Lamothe, M. Develoux, B. Sellin and F. Mouchet, 1990. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Nigeria after four consecutive years of treatment with praziquantel. Trop. Med. Parasitol., 41: 139-142.

Liang, Y.S., G.C. Coles and M.I. Doenhoff, 2000. Short communication: Detection of praziquantel resistance in schistosomes. Trop. Med. Int. Health, 5: 72-72.
CrossRef  |  Direct Link  |  

Maclean, G. and U. Hay, 1954. An experiment in the control of schistosomiasis; first report. Ann. Trop. Med. Parasit., 48: 21-27.
Direct Link  |  

McMahon, J.E. and N. Kolstrup, 1979. Praziquantel: A new schistomicide against Schistosoma haematobium. Br. Med. J., 2: 1396-1399.

McManus, D.P. and M. Hope, 1993. Drug resistance and drug resistance studies. Acta Tropica, 54: 260-267.

Olds, G.R., C. King, J. Hewlett, R. Olveda and G. Wu et al., 1999. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J. Infect. Dis., 179: 996-1003.
CrossRef  |  Direct Link  |  

Oomen, J.M., D.R. Bell and S. Reddy, 1975. Metrifonate in urinary schistosomiasis: A field trial in northern Nigeria. Ann. Trop. Med. Parasitol., 69: 73-76.
PubMed  |  

Pereira, C., P.G. Fallon, J. Cornette, A. Capron, M.J. Doenhoff and R.J. Pierce, 1998. Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni. Parasitology, 117: 63-73.
PubMed  |  

Reich, M.R. and R. Govindaraj, 1998. Dilemmas in drug development for tropical diseases: Experiences with praziquantel. Health Policy, 44: 1-18.
CrossRef  |  Direct Link  |  

Reich, M.R. and R. Govindaraj, 2014. Demand for Praziquqntel and National Distribution. In: International Strategies for Tropical Disease Treatments Experiences with Praziquantel, Reich, M.R. (Ed.). WHO, Geneva, pp: 67-81.

Renganathan, E. and D. Cioli, 1998. An international initiative on praziquantel use. Parasitol. Today, 14: 390-401.
CrossRef  |  PubMed  |  

Savioli, L., L. Chitsulo and A. Montresor, 1999. New opportunities for the control of fascioliasis. Bull. World Health Organiz., 77: 300-300.
PubMed  |  

Shaw, D.J., J. Vercruysse, M. Picquet, B. Sambou and A. Ly, 1999. The effect of different treatment regimens on the epidemiology of seasonally transmitted Schistosoma haematobium infections in four villages in the Senegal River Basin, Senegal. Trans. R. Soc. Trop. Med. Hyg., 93: 142-150.
PubMed  |  

Taddese, K. and Z.A. Zein, 1988. Comparison between the efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infections on a sugar estate in Ethiopia. Ann. Trop. Med. and Parasitol., 82: 173-180.
PubMed  |  

Taylor, P., H.M. Murare and K. Manomano, 1988. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium. J. Trop. Med. Hyg., 91: 13-17.
Direct Link  |  

WHO, 1985. The control of schistosomiasis. Technical Report Series No. 728, World Health Organization, pp: 113.

Wilkins, H.A., U.J. Blumenthal, P. Hagan, R.J. Hayes and S. Tulloch, 1987. Resistance to reinfection after treatment of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg., 81: 29-35.
CrossRef  |